Skip to main content
Journal cover image

Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.

Publication ,  Journal Article
Amdur, RL; Feldman, HI; Dominic, EA; Anderson, AH; Beddhu, S; Rahman, M; Wolf, M; Reilly, M; Ojo, A; Townsend, RR; Go, AS; He, J; Xie, D ...
Published in: Am J Kidney Dis
March 2019

RATIONALE & OBJECTIVE: Traditional risk estimates for atherosclerotic vascular disease (ASVD) and death may not perform optimally in the setting of chronic kidney disease (CKD). We sought to determine whether the addition of measures of inflammation and kidney function to traditional estimation tools improves prediction of these events in a diverse cohort of patients with CKD. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: 2,399 Chronic Renal Insufficiency Cohort (CRIC) Study participants without a history of cardiovascular disease at study entry. PREDICTORS: Baseline plasma levels of biomarkers of inflammation (interleukin 1β [IL-1β], IL-1 receptor antagonist, IL-6, tumor necrosis factor α [TNF-α], transforming growth factor β, high-sensitivity C-reactive protein, fibrinogen, and serum albumin), measures of kidney function (estimated glomerular filtration rate [eGFR] and albuminuria), and the Pooled Cohort Equation probability (PCEP) estimate. OUTCOMES: Composite of ASVD events (incident myocardial infarction, peripheral arterial disease, and stroke) and death. ANALYTICAL APPROACH: Cox proportional hazard models adjusted for PCEP estimates, albuminuria, and eGFR. RESULTS: During a median follow-up of 7.3 years, 86, 61, 48, and 323 participants experienced myocardial infarction, peripheral arterial disease, stroke, or death, respectively. The 1-decile greater levels of IL-6 (adjusted HR [aHR], 1.12; 95% CI, 1.08-1.16; P<0.001), TNF-α (aHR, 1.09; 95% CI, 1.05-1.13; P<0.001), fibrinogen (aHR, 1.07; 95% CI, 1.03-1.11; P<0.001), and serum albumin (aHR, 0.96; 95% CI, 0.93-0.99; P<0.002) were independently associated with the composite ASVD-death outcome. A composite inflammation score (CIS) incorporating these 4 biomarkers was associated with a graded increase in risk for the composite outcome. The incidence of ASVD-death increased across the quintiles of risk derived from PCEP, kidney function, and CIS. The addition of eGFR, albuminuria, and CIS to PCEP improved (P=0.003) the area under the receiver operating characteristic curve for the composite outcome from 0.68 (95% CI, 0.66-0.71) to 0.73 (95% CI, 0.71-0.76). LIMITATIONS: Data for cardiovascular death were not available. CONCLUSIONS: Biomarkers of inflammation and measures of kidney function are independently associated with incident ASVD events and death in patients with CKD. Traditional cardiovascular risk estimates could be improved by adding markers of inflammation and measures of kidney function.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Kidney Dis

DOI

EISSN

1523-6838

Publication Date

March 2019

Volume

73

Issue

3

Start / End Page

344 / 353

Location

United States

Related Subject Headings

  • Young Adult
  • Urology & Nephrology
  • Renal Insufficiency, Chronic
  • Predictive Value of Tests
  • Middle Aged
  • Male
  • Kidney Function Tests
  • Inflammation
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Amdur, R. L., Feldman, H. I., Dominic, E. A., Anderson, A. H., Beddhu, S., Rahman, M., … CRIC Study Investigators, . (2019). Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study. Am J Kidney Dis, 73(3), 344–353. https://doi.org/10.1053/j.ajkd.2018.09.012
Amdur, Richard L., Harold I. Feldman, Elizabeth A. Dominic, Amanda H. Anderson, Srinivasan Beddhu, Mahboob Rahman, Myles Wolf, et al. “Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.Am J Kidney Dis 73, no. 3 (March 2019): 344–53. https://doi.org/10.1053/j.ajkd.2018.09.012.
Amdur RL, Feldman HI, Dominic EA, Anderson AH, Beddhu S, Rahman M, et al. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study. Am J Kidney Dis. 2019 Mar;73(3):344–53.
Amdur, Richard L., et al. “Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.Am J Kidney Dis, vol. 73, no. 3, Mar. 2019, pp. 344–53. Pubmed, doi:10.1053/j.ajkd.2018.09.012.
Amdur RL, Feldman HI, Dominic EA, Anderson AH, Beddhu S, Rahman M, Wolf M, Reilly M, Ojo A, Townsend RR, Go AS, He J, Xie D, Thompson S, Budoff M, Kasner S, Kimmel PL, Kusek JW, Raj DS, CRIC Study Investigators. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study. Am J Kidney Dis. 2019 Mar;73(3):344–353.
Journal cover image

Published In

Am J Kidney Dis

DOI

EISSN

1523-6838

Publication Date

March 2019

Volume

73

Issue

3

Start / End Page

344 / 353

Location

United States

Related Subject Headings

  • Young Adult
  • Urology & Nephrology
  • Renal Insufficiency, Chronic
  • Predictive Value of Tests
  • Middle Aged
  • Male
  • Kidney Function Tests
  • Inflammation
  • Humans
  • Female